<DOC>
	<DOCNO>NCT01193270</DOCNO>
	<brief_summary>The purpose pilot trial test safety efficacy administer one dose vitamin E , via tube stomach , extremely preterm infant ( less 27 week gestation le 1000 gram birth weight ) . This pilot examine whether single dose vitamin E absorb infant ' bloodstream result serum α-tocopherol level target range 1-3 mg/dl .</brief_summary>
	<brief_title>Vitamin E Extremely Preterm Infants</brief_title>
	<detailed_description>Intraventricular hemorrhage ( IVH ) -- bleed brain 's ventricular system -- one common complication prematurity , affect estimate 10-40 % low birth weight ( &lt; 1500 g ) infants born less 35 week gestation . Mortality severe ( high-grade ) IVH 27-50 % . Severe IVH result developmental delay life-long neurological deficit , include cerebral palsy seizure . A number strategy use effort prevent IVH , include : antenatal corticosteroid , maternal vitamin K , delay clamp umbilical cord , indomethacin , ethamsylate , inositol , muscle paralysis . With exception antenatal corticosteroid indomethacin , measure meet limited success . Supplemental vitamin E , give first hour life premature infant , offer promise low-risk approach prevent and/or lessen severity IVH . This safety efficacy pilot trial examine whether one dose vitamin E ( dl-α-tocopheryl acetate ) , give intragastrically preterm infant &lt; 27 week gestation &lt; 1000 gram birth weight , produce blood serum α-tocopherol level target range 1-3 mg/dl . Based result pilot , Phase III randomize control trial develop test whether single dose vitamin E reduce incidence death neurodevelopmental impairment 18-22 month correct age preterm infant . Most intraventricular hemorrhage occur first 72 hour birth . Because , prevent IVH , must give soon possible birth . Eligible , consented infant assign either vitamin E group placebo group . Infants vitamin E group receive 1.0 ml/kg dl-α-tocopheryl acetate ( Aquasol E® ) ; infant placebo control group receive similar amount sterile water . The dose give within 4 hour birth via tube stomach . Blood sample take infant dose give , 24 hour dose , 7 day dose measure well vitamin E absorb bloodstream .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Less 27 complete week gestational age Birth weight less 1,000 gram Inborn infant Infant 's treatment limit base poor prognosis Umbilical cord blood pH 7.0 Antenatally diagnose brain abnormality , include hemorrhage Major congenital malformation , include feed contraindicate Mother infant enrol clinical trial vitamin E supplementation Mother infant report self administration monovitamin supplement vitamin E pregnancy labor Infant receive supplemental vitamin E ( except multivitamin additive parenteral nutrition enteral milk formula feed ) Greater four hour age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Hours</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Intraventricular Hemorrhage ( IVH )</keyword>
	<keyword>Very Low Birth Weight ( VLBW )</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW )</keyword>
	<keyword>Prematurity</keyword>
</DOC>